Method of manufacturing a protein by perfusion in media with a low amino acid concentration
Perfusion media are disclosed providing excellent cell density, titer and product quality for production of a therapeutic protein in a perfusion process.
1. A method for producing a therapeutic protein comprising the steps of:
(a) preparing a mixture comprising Chinese Hamster Ovary (CHO) cells capable of expressing the protein, and a culture medium suitable for conducting such expression;
(b) in a suitable vessel containing the mixture, causing the cells to produce the protein having a viable cell density of at least 10 million cells per milliliter; and
(c) periodically or continuously removing spent culture medium from, and adding fresh culture medium to, the reaction vessel,
wherein the culture medium comprises (i) a total amino acid concentration of 15 to 65 mM and (ii) a CHO cell base medium and cottonseed hydrolysate.
2. The method of claim 1 , wherein the protein is a TNFR (tumor necrosis factor receptor)-Fc fusion protein or an anti-TNF antibody.
3. The method of claim 1 , wherein a viable cell density of at least 20×10 6 cells/mL is maintained for at least 96 hours in a culture in the step of producing the protein.
4. The method of claim 1 , wherein the feed medium comprises a total amino acid concentration in a range selected from the group consisting of: 15 to 20 mM; 20 to 25 mM; 25 to 30 mM; 30 to 35 mM; 35 to 40 mM; 40 to 45 mM; 45 to 50 mM; 50 to 55 mM; 55 to 60 mM; and 60 to 65 mM.
5. The method of claim 1 , wherein the protein is selected from the group consisting of etanercept, adalimumab, infliximab, and a biosimilar thereof.
6. The method of claim 1 , wherein, prior to the protein production step, the CHO cells are grown in a growth phase at a temperature selected from (i) 28° to 37° C. and (ii) 35° to 36° C.
7. The method of claim 6 , wherein the protein production step is carried out at a temperature selected from (i) greater than 32° C.; (ii) greater than 34° C.; (iii) greater than 35° C.; (iv) the range of 33° C. to 36° C.; (v) the range of 35° C. to 36° C.; (vi) 32.5° C.; (vii) 33.5° C.; (viii) 34.5° C.; and (ix) 35.5° C.
8. The method of claim 1 , wherein a protein titer of at least 300 μg/mL is achieved in the step of producing the protein.
9. The method of claim 1 , wherein less than 40 mM of ammonia is produced in the step of producing the protein.
10. The method of claim 1 , wherein the culture medium further comprises a CHO cell chemically-defined feed, glutamine, or a combination thereof.
11. The method of claim 1 , wherein the culture medium comprises (i) a total amino acid concentration of 15 to 65 mM and (ii) a CHO cell base medium, a CHO cell chemically-defined feed, and dexamethasone.
12. The method of claim 1 , wherein the culture medium comprises (i) a total amino acid concentration of 15 to 65 mM and (ii) a CHO cell base medium, a CHO cell chemically-defined feed, and ManNAc.
13. The method of claim 1 , wherein the culture medium further comprises a CHO cell chemically-defined feed.
14. The method of claim 1 , wherein the culture medium further comprises D-(+)-galactose.
15. The method of claim 1 , wherein the culture medium further comprises dexamethasone.
16. The method of claim 1 , wherein the culture medium further comprises ManNAc.
17. The method of claim 1 , wherein the culture medium further comprises glutamine.
18. The method of claim 1 , wherein the culture medium further comprises at least two of a CHO cell chemically-defined feed, dexamethasone, galactose and ManNAc.
19. The method of claim 1 , wherein the culture medium comprises (i) a total amino acid concentration of 15 to 45 mM and (ii) further comprises at least one of a CHO cell chemically-defined feed, dexamethasone, galactose and N-acetylmannosamine (ManNAc).
20. A method for producing a TNFR (tumor necrosis factor receptor)-Fc fusion protein or an anti-TNF antibody comprising the steps of:
(a) preparing a mixture comprising Chinese Hamster Ovary (CHO) cells capable of expressing the TNFR (tumor necrosis factor receptor)-Fc fusion protein or anti-TNF antibody, and a culture medium suitable for conducting such expression;
(b) in a suitable vessel containing the mixture, causing the cells to produce the TNFR (tumor necrosis factor receptor)-Fc fusion protein or anti-TNF antibody having a viable cell density of at least 10 million cells per milliliter; and
(c) periodically or continuously removing spent culture medium from, and adding fresh culture medium to, the reaction vessel,
wherein the culture medium comprises (i) a total amino acid concentration of 15 to 30 mM and (ii) a CHO cell base medium and at least one of a CHO cell chemically-defined feed, glutamine, dexamethasone, ManNAc (N-acetylmannosamine), cottonseed hydrolysate, and D-(+)-galactose.